InsiderTrades

Form 4 for REGN Regeneron Pharmaceuticals

Accepted 2024-06-13 00:00:00 ET · period of report 2024-06-11 · accession 0001104659-24-071247 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2024-06-13 2024-06-11+ REGN SCHLEIFER LEONARD S Pres, CEO, Bd. Co-COB, Dir S - Sale $1,015.75 -25.2K 0 -100% -$25.61M
DI 2024-06-13 2024-06-12 REGN SCHLEIFER LEONARD S Pres, CEO, Bd. Co-COB, Dir C - Cnv Deriv $0.00 +1,000 1,000 New $0
DI 2024-06-13 2024-06-12 REGN SCHLEIFER LEONARD S Pres, CEO, Bd. Co-COB, Dir C - Cnv Deriv $0.00 -1,000 14.8K -6% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-11 S D 7,321 $1,015.28 56,877 I By Trust — — (F2) Represents volume-weighted average price of sales of 7,321 shares of common stock of Regeneron Pharmaceuticals, Inc. (the "Company") on June 11, 2024 at prices ranging from $1,015.00 to $1,015.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2024 at each separate price.
2 Common Common Stock 2024-06-12 C A 1,000 $0.00 1,000 I by Trust for Son — —
3 Common Common Stock 2024-06-12 S D 270 $1,016.62 39,985 I By Trust — — (F5) Represents volume-weighted average price of sales of 270 shares of Company stock on June 12, 2024 at prices ranging from $1,016.10 to $1,016.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
4 Common Common Stock 2024-06-12 S D 14,879 $1,015.30 40,255 I By Trust — — (F4) Represents volume-weighted average price of sales of 14,879 shares of Company stock on June 12, 2024 at prices ranging from $1,015.00 to $1,015.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
5 Common Common Stock 2024-06-11 S D 1,743 $1,016.04 55,134 I By Trust — — (F3) Represents volume-weighted average price of sales of 1,743 shares of Company stock on June 11, 2024 at prices ranging from $1,016.04 to $1,016.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2024 at each separate price.
6 Common Common Stock 2024-06-12 S D 1,000 $1,025.27 0 I by Trust for Son — — (F6) Represents volume-weighted average price of sales of 1,000 shares of Company stock on June 12, 2024 at prices ranging from $1,025.00 to $1,025.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
7 Derivative Class A Stock 2024-06-12 C D 1,000 $0.00 14,775 I by Trust for Son $0.00 · — to — 1,000 Common Stock (F7) Class A Stock of the Company converts to common stock of the Company on a one-to-one basis upon certain events or upon election of the shareholder. (F8) These shares of Class A Stock are presently convertible and such conversion feature does not expire.